Inspire Medical Systems Inc (N:INSP)

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
See Regulatory Filings on SEC
Company Contact
Address: 5500 Wayzata Blvd Ste 1600
Tel: N/A
IR: See website
Key People
Timothy P. Herbert
Chairman of the Board, President, Chief Executive Officer
Richard J. Buchholz
Chief Financial Officer
Philip J. Ebeling
Chief Operating Officer
Bryan K. Phillips
Senior Vice President, Chief Compliance Officer, General Counsel, Company Secretary
John Rondoni
Chief Technology Officer
Steven L. Jandrich
Vice President of Human Resources
Randall A. Ban
Chief Commercial Officer
Charisse Y. Sparks
Chief Medical Officer
Carlton Weatherby
Chief Strategy Officer
Business Overview
Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire system is the FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The Company has developed a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sell its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ENT physicians and sleep centers.
Financial Overview
For the three months ended 31 March 2024, Inspire Medical Systems Inc revenues increased 28% to $164M. Net loss decreased 35% to $10M. Revenues reflect United States segment increase of 25% to $155.8M, All other countries segment increase from $3.4M to $8.2M. Lower net loss reflects Interest and dividend income increase of 39% to $5.9M (income). Basic Earnings per Share excluding Extraordinary Items increased from -$0.53 to -$0.34.
Employees: 1,011 as of Dec 31, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $4,172M as of Mar 31, 2024
Annual revenue (TTM): $660.91M as of Mar 31, 2024
EBITDA (TTM): -$32.90M as of Mar 31, 2024
Net annual income (TTM): -$15.73M as of Mar 31, 2024
Free cash flow (TTM): $3.29M as of Mar 31, 2024
Net Debt Last Fiscal Year: N/A
Shares outstanding: 29,711,048 as of May 1, 2024
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.